Economic factors are increasingly important when selecting and justifying use of new and even existing products in surgery. A new article, published in Public Service Review: Health and Social Care 28, proposes that healthcare economic arguments should not be merely an essential consideration, but rather can be used to actively provoke adoption of new technologies. The specific focus of the article is on the use of Tissuemed’s TissuePatch products as a means of improving outcome and therefore reducing cost of care, by reducing the need for continued treatment or extended hospitalisation. The full article, entitled; “Healthcare Economics; The Driver for adoption of a new surgical technology” can be seen by clicking Healthcare Economic Article. The article concludes; “TissuePatch is a real-world example of technology adoption requiring a product to be in the sweet spot of improving surgical outcomes with associated cost savings”.